![Casper Breum](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Casper Breum
Fondatore presso
Sound Bioventures Management ApS
Profilo
Casper Breum is the founder of Sound Bioventures Management ApS, serving as Managing Partner since 2021.
Current jobs include Director at Sanifit Therapeutics SA since 2015, Director at VarmX BV since 2020, and Senior Advisor at Lundbeckfonden Ventures since 2021.
Former jobs include Chief Executive Officer at ilochip Bioscience A, Director at Asante Solutions, Inc., Director at Aura Biosciences, Inc., Director at Lundbeckfond Invest A, Director at Lundbeckfonden, Director at Nexstim Oyj, Director at DYSIS Medical Ltd. from 2013 to 2021, Director at Biom'Up SA, Director at Atox Bio Ltd. from 2017 to 2021, Director at Spero Therapeutics, Inc. from 2015 to 2018, Principal at Novo Nordisk A, and Manager-Business Development at H.
Lundbeck A. Education includes a graduate degree from Technical University of Denmark conferred in 1992 and an MBA from Technical University of Denmark conferred in 2001.
Posizioni attive di Casper Breum
| Società | Posizione | Inizio |
|---|---|---|
Lundbeckfonden Ventures
 Lundbeckfonden Ventures Investment ManagersFinance Lundbeckfonden Ventures is an active manager which provides equity funding for early and later-stage capital requirements, and provides management support. The firm targets companies operating in health technology sector, industries such as pharmaceuticals. Lundbeckfonden Ventures invests in companies located in Europe and North America, and looks to take minority stake positions in its investments, as well as a seat on the board. | Consulente / Consigliere | 01/10/2009 |
Sanifit Therapeutics SA
 Sanifit Therapeutics SA BiotechnologyHealth Technology Operates as a clinical-stage biopharmaceutical company that develops pharmaceuticals for calcification disorders | Direttore/Membro del Consiglio | 01/07/2015 |
Varmx BV
 Varmx BV BiotechnologyHealth Technology Develops and manufactures therapeutic proteins to restore hemostasis | Direttore/Membro del Consiglio | 01/07/2020 |
Sound Bioventures Management ApS
 Sound Bioventures Management ApS Investment ManagersFinance Functions as an alternative investment manager | Fondatore | 01/01/2021 |
Precedenti posizioni note di Casper Breum
| Società | Posizione | Fine |
|---|---|---|
DYSIS Medical Ltd.
 DYSIS Medical Ltd. Medical SpecialtiesHealth Technology Manufactures and distributes technological medical equipment for cervical cancer diagnostics | Direttore/Membro del Consiglio | 31/10/2021 |
Atox Bio Ltd.
 Atox Bio Ltd. BiotechnologyHealth Technology Provides novel immune modulators for critically ill patients with severe infections | Direttore/Membro del Consiglio | 31/10/2021 |
| SPERO THERAPEUTICS, INC. | Direttore/Membro del Consiglio | 21/09/2018 |
ilochip Bioscience A/S
 ilochip Bioscience A/S SemiconductorsElectronic Technology Develops lab-on-chip technology for identification of pathogens to detect bio terror agents | Amministratore Delegato | 04/08/2010 |
| AURA BIOSCIENCES, INC. | Direttore/Membro del Consiglio | - |
Formazione di Casper Breum
Esperienze
Posizioni ricoperte
Attive
Inattive
Società nel listino
Aziende private
Relazioni
81
Relazioni di 1° grado
17
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 17 |
|---|---|
Novo Nordisk A/S
 Novo Nordisk A/S Pharmaceuticals: MajorHealth Technology Manufactures and markets pharmaceutical products for diabetes care | Health Technology |
H. Lundbeck A/S
 H. Lundbeck A/S Pharmaceuticals: MajorHealth Technology Engages in the research, development, production and sale of pharmaceuticals for the treatment of brain diseases | Health Technology |
Asante Solutions, Inc.
 Asante Solutions, Inc. Medical SpecialtiesHealth Technology Develops insulin delivery devices | Health Technology |
Aura Biosciences, Inc.
 Aura Biosciences, Inc. BiotechnologyHealth Technology Operates as a clinical-stage biotechnology company leveraging novel targeted oncology platform to develop new standard of care across multiple cancer indications | Health Technology |
Lundbeckfond Invest A/S
 Lundbeckfond Invest A/S Investment ManagersFinance Lundbeckfond Invest is an active, long-term manager which aims to achieve stable returns with moderate risk to maintain or increase the purchasing power of the portfolio assets and provide a relatively predictable and stable real return to be used for awarding grants. They invest in a variety of instruments including Danish bonds, corporate bonds, cash and cash equivalents, equities, private equity, lifescience companies and real estate. The portfolio must not include any unusual risks with respect to geography, sectors, companies or political stability and must mainly invest in listed assets. The Lundbeck Foundation's Board of Trustees determines the investment policy and appoints an Investment Committee to implement it. They share responsibility for the strategic and tactical allocation of assets and risk management with the executive management of the Foundation and with the Investment Department. The Investment Department manages the portfolio in collaboration with external managers. Risk management is an integral part of investment management. Lundbeckfond Invest manages market risk by setting limits per asset class. They also set maximum limits for the duration of the bond portfolio. Liquidity risk is managed by limits on the proportion of the portfolio invested in non-liquid assets (private equity). In addition to these limits, the portfolio's Value-at-Risk is monitored in order to control and manage current market risk. | Finance |
Lundbeckfonden
 Lundbeckfonden Investment Trusts/Mutual FundsMiscellaneous Functions as a foundation or endowment | Miscellaneous |
Technical University of Denmark
 Technical University of Denmark Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Nexstim Oyj
 Nexstim Oyj Medical SpecialtiesHealth Technology Develops non-invasive brain stimulation technology | Health Technology |
DYSIS Medical Ltd.
DYSIS Medical Ltd. Medical SpecialtiesHealth Technology Manufactures and distributes technological medical equipment for cervical cancer diagnostics | Health Technology |
ilochip Bioscience A/S
ilochip Bioscience A/S SemiconductorsElectronic Technology Develops lab-on-chip technology for identification of pathogens to detect bio terror agents | Electronic Technology |
Sanifit Therapeutics SA
Sanifit Therapeutics SA BiotechnologyHealth Technology Operates as a clinical-stage biopharmaceutical company that develops pharmaceuticals for calcification disorders | Health Technology |
Biom'Up SA
 Biom'Up SA Medical SpecialtiesHealth Technology Manufactures medical devices based on collagen technology | Health Technology |
Lundbeckfonden Ventures
Lundbeckfonden Ventures Investment ManagersFinance Lundbeckfonden Ventures is an active manager which provides equity funding for early and later-stage capital requirements, and provides management support. The firm targets companies operating in health technology sector, industries such as pharmaceuticals. Lundbeckfonden Ventures invests in companies located in Europe and North America, and looks to take minority stake positions in its investments, as well as a seat on the board. | Finance |
Atox Bio Ltd.
Atox Bio Ltd. BiotechnologyHealth Technology Provides novel immune modulators for critically ill patients with severe infections | Health Technology |
Spero Therapeutics, Inc.
 Spero Therapeutics, Inc. BiotechnologyHealth Technology Develops therapies for the treatment of bacterial infections | Health Technology |
Varmx BV
Varmx BV BiotechnologyHealth Technology Develops and manufactures therapeutic proteins to restore hemostasis | Health Technology |
Sound Bioventures Management ApS
Sound Bioventures Management ApS Investment ManagersFinance Functions as an alternative investment manager | Finance |
